Cargando…

An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma(✰)()

BACKGROUND & AIMS: Management of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is not well-defined. Therefore, we evaluated the management of cHCC-CCA using an online hospital-wide multicentre survey sent to expert centres. METHODS: A survey was sent to members of the European Network fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claasen, Marco P.A.W., Ivanics, Tommy, Beumer, Berend R., de Wilde, Roeland F., Polak, Wojciech G., Sapisochin, Gonzalo, IJzermans, Jan N.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206495/ https://www.ncbi.nlm.nih.gov/pubmed/37234277 http://dx.doi.org/10.1016/j.jhepr.2023.100745

Ejemplares similares

The management of post-transplantation recurrence of hepatocellular carcinoma
por: Rajendran, Luckshi, et al.
Publicado: (2022)

Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
por: Choi, Woo Jin, et al.
Publicado: (2023)

Trends in liver transplantation for autoimmune liver diseases: a Canadian study
por: Murillo Perez, Carla F., et al.
Publicado: (2022)

The Treatment Effect of Liver Transplantation versus Liver Resection for HCC: A Review and Future Perspectives
por: Beumer, Berend R., et al.
Publicado: (2021)

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group
por: Beumer, Berend R, et al.
Publicado: (2022)

Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis
por: Yoon, Peter D., et al.
Publicado: (2022)

National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors
por: Wallace, David, et al.
Publicado: (2021)

Pushing the limits for the surgical treatment of intrahepatic cholangiocarcinoma
por: Choi, Woo Jin, et al.
Publicado: (2023)

Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Holster, Jessica J., et al.
Publicado: (2022)

Impact of sarcopenia on clinical outcomes for patients with resected hepatocellular carcinoma: a retrospective comparison of Eastern and Western cohorts
por: Beumer, Berend R., et al.
Publicado: (2023)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
por: Beumer, Berend R., et al.
Publicado: (2022)

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
por: Hoogwater, Frederik J H, et al.
Publicado: (2023)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Prediction of Early Recurrence After Surgery for Liver Tumor (ERASL): An International Validation of the ERASL Risk Models
por: Beumer, Berend R., et al.
Publicado: (2021)

Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis
por: Takagi, Kosei, et al.
Publicado: (2019)

Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment()
por: Hernandez, Matthew C., et al.
Publicado: (2018)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
por: Bahra, Marcus, et al.
Publicado: (2023)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Surgery for cholangiocarcinoma
por: Cillo, Umberto, et al.
Publicado: (2019)

Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma
por: Gaspersz, Marcia P., et al.
Publicado: (2019)

Management and outcome of hepatocellular adenoma with massive bleeding at presentation
por: Klompenhouwer, Anne J, et al.
Publicado: (2017)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Combined liver-kidney transplantation with delayed kidney implantation: A case report
por: Bouari, Sarah, et al.
Publicado: (2023)

Phenotype or Genotype: Decision‐Making Dilemmas in Hepatocellular Adenoma
por: Klompenhouwer, Anne J., et al.
Publicado: (2019)

Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study
por: Visseren, Thijmen, et al.
Publicado: (2022)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Association of Laparoscopic Surgery with Improved Perioperative and Survival Outcomes in Patients with Resectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis from Propensity-Score Matched Studies
por: Aliseda, Daniel, et al.
Publicado: (2023)

Call to Improve the Quality of Prediction Tools for Intrahepatic Cholangiocarcinoma Resection: A Critical Appraisal, Systematic Review, and External Validation Study
por: Choi, Woo Jin, et al.
Publicado: (2023)

Management strategy after diagnosis of Abernethy malformation: a case report
por: Witjes, Caroline DM, et al.
Publicado: (2012)

GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma
por: van Beek, Adriaan A., et al.
Publicado: (2019)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Breast Metastasis From a Combined Hepatocellular–Cholangiocarcinoma
por: Silva, Marco, et al.
Publicado: (2019)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dnkur83m28u30m1rdicd5t2kl4